Oliveira Jocelânio W, Valença Dione M, Medeiros Pledson G, Marçula Magaly
Instituto de Matemática e Estatística, USP, 05508-090, São Paulo, Brazil.
Departamento de Estatística, CCET, UFRN, 59078-970, Natal, Brazil.
Biom J. 2016 Nov;58(6):1485-1505. doi: 10.1002/bimj.201500094. Epub 2016 Sep 20.
The use of control charts for monitoring schemes in medical context should consider adjustments to incorporate the specific risk for each individual. Some authors propose the use of a risk-adjusted survival time cumulative sum (RAST CUSUM) control chart to monitor a time-to-event outcome, possibly right censored, using conventional survival models, which do not contemplate the possibility of cure of a patient. We propose to extend this approach considering a risk-adjusted CUSUM chart, based on a cure rate model. We consider a regression model in which the covariates affect the cure fraction. The CUSUM scores are obtained for Weibull and log-logistic promotion time model to monitor a scale parameter for nonimmune individuals. A simulation study was conducted to evaluate and compare the performance of the proposed chart (RACUF CUSUM) with RAST CUSUM, based on optimal control limits and average run length in different situations. As a result, we note that the RAST CUSUM chart is inappropriate when applied to data with a cure rate, while the proposed RACUF CUSUM chart seems to have similar performance if applied to data without a cure rate. The proposed chart is illustrated with simulated data and with a real data set of patients with heart failure treated at the Heart Institute (InCor), at the University of São Paulo, Brazil.
在医学背景下,用于监测方案的控制图的使用应考虑进行调整,以纳入每个个体的特定风险。一些作者提议使用风险调整生存时间累积和(RAST CUSUM)控制图,通过传统生存模型来监测可能存在右删失的事件发生时间结局,而传统生存模型未考虑患者治愈的可能性。我们提议基于治愈率模型,通过考虑风险调整CUSUM图来扩展这种方法。我们考虑一个回归模型,其中协变量影响治愈比例。针对威布尔和对数逻辑斯蒂促进时间模型获得CUSUM分数,以监测非免疫个体的尺度参数。进行了一项模拟研究,基于不同情况下的最优控制限和平均运行长度,评估并比较所提议的控制图(RACUF CUSUM)与RAST CUSUM的性能。结果,我们注意到当应用于具有治愈率的数据时,RAST CUSUM控制图不合适,而如果应用于无治愈率的数据,所提议的RACUF CUSUM控制图似乎具有相似的性能。所提议的控制图通过模拟数据以及巴西圣保罗大学心脏研究所(InCor)治疗的心力衰竭患者的真实数据集进行说明。